ITRM20000567A0 - Composizioni solide atte alla somministrazione orale comprendenti sali non igroscopici della l-carnitina e delle alcanoil l-carnitine con l' - Google Patents

Composizioni solide atte alla somministrazione orale comprendenti sali non igroscopici della l-carnitina e delle alcanoil l-carnitine con l'

Info

Publication number
ITRM20000567A0
ITRM20000567A0 IT2000RM000567A ITRM20000567A ITRM20000567A0 IT RM20000567 A0 ITRM20000567 A0 IT RM20000567A0 IT 2000RM000567 A IT2000RM000567 A IT 2000RM000567A IT RM20000567 A ITRM20000567 A IT RM20000567A IT RM20000567 A0 ITRM20000567 A0 IT RM20000567A0
Authority
IT
Italy
Prior art keywords
carnitine
alkanoyl
oral administration
compositions suitable
including non
Prior art date
Application number
IT2000RM000567A
Other languages
English (en)
Inventor
Maria Ornella Tinti
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of ITRM20000567A0 publication Critical patent/ITRM20000567A0/it
Priority to IT2000RM000567A priority Critical patent/IT1317924B1/it
Priority to AU9589301A priority patent/AU9589301A/xx
Priority to SI200130462T priority patent/SI1330428T1/sl
Priority to JP2002539304A priority patent/JP4181406B2/ja
Priority to HU0302294A priority patent/HU229989B1/hu
Priority to ES01976633T priority patent/ES2253430T3/es
Priority to KR1020037005596A priority patent/KR100764155B1/ko
Priority to US10/415,472 priority patent/US7858820B2/en
Priority to PCT/IT2001/000503 priority patent/WO2002036543A1/en
Priority to CA2427482A priority patent/CA2427482C/en
Priority to CNB018182941A priority patent/CN1219748C/zh
Priority to SK501-2003A priority patent/SK287133B6/sk
Priority to AT01976633T priority patent/ATE312810T1/de
Priority to RU2003116133/04A priority patent/RU2270191C2/ru
Priority to BRPI0115019A priority patent/BRPI0115019B1/pt
Priority to PL364823A priority patent/PL205801B1/pl
Priority to DE60115944T priority patent/DE60115944T2/de
Priority to DK01976633T priority patent/DK1330428T3/da
Priority to AU2001295893A priority patent/AU2001295893B2/en
Priority to EP01976633A priority patent/EP1330428B1/en
Priority to CZ20031041A priority patent/CZ302802B6/cs
Priority to NZ525333A priority patent/NZ525333A/en
Priority to MXPA03003799A priority patent/MXPA03003799A/es
Publication of ITRM20000567A1 publication Critical patent/ITRM20000567A1/it
Priority to ZA200303328A priority patent/ZA200303328B/en
Application granted granted Critical
Publication of IT1317924B1 publication Critical patent/IT1317924B1/it
Priority to HK04104342A priority patent/HK1061230A1/xx
Priority to CY20061100074T priority patent/CY1106062T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/22—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/24—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one carboxyl group bound to the carbon skeleton, e.g. aspartic acid
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A23L33/22—Comminuted fibrous parts of plants, e.g. bagasse or pulp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/08—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to hydrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C309/13—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton
    • C07C309/14—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton containing amino groups bound to the carbon skeleton
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Nutrition Science (AREA)
  • Botany (AREA)
  • Neurology (AREA)
  • Mycology (AREA)
  • Obesity (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Biomedical Technology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fodder In General (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
IT2000RM000567A 2000-10-31 2000-10-31 Composizioni solide atte alla somministrazione orale comprendenti salinon igroscopici della l-carnitina e delle alcanoil l-carnitine con IT1317924B1 (it)

Priority Applications (26)

Application Number Priority Date Filing Date Title
IT2000RM000567A IT1317924B1 (it) 2000-10-31 2000-10-31 Composizioni solide atte alla somministrazione orale comprendenti salinon igroscopici della l-carnitina e delle alcanoil l-carnitine con
AT01976633T ATE312810T1 (de) 2000-10-31 2001-09-28 Feste zusammensetzungen für orale verabreichung die nicht-hygroskopische salze von l-karnitin und alkanoyl-l-karnitin mit taurinchlorid enthalten
BRPI0115019A BRPI0115019B1 (pt) 2000-10-31 2001-09-28 composições sólidas adequadas para administração oral contendo sais não-higroscópicos de l-carnitina e as l-carnitinas e alcanoíla com cloreto de taurina e cloreto de glicina
JP2002539304A JP4181406B2 (ja) 2000-10-31 2001-09-28 Ｌ−カルニチンおよびアルカノイルｌ−カルニチンとタウリンクロリドおよびグリシンクロリドとの非吸湿性塩を含有する経口投与に好適な固形組成物
HU0302294A HU229989B1 (hu) 2000-10-31 2001-09-28 L-karnitin és alkanoil-L-karnitin taurin-kloriddal és glicin-kloriddal alkotott nem higroszkópos sói és ezeket tartalmazó, orális beadásra alkalmas szilárd készítmények
ES01976633T ES2253430T3 (es) 2000-10-31 2001-09-28 Composiciones solidas adecuadas para la administracion oral que contienen sales no higroscopicas de l-carnitina y las alcanoil l-carnitinas con cloruro de taurina.
KR1020037005596A KR100764155B1 (ko) 2000-10-31 2001-09-28 타우린 클로라이드와의 ｌ-카르니틴 및 알카노일 ｌ-카르니틴의 비 흡습성 염을 함유하는 경구 투여에 적합한 고형 조성물
US10/415,472 US7858820B2 (en) 2000-10-31 2001-09-28 Solid compositions suitable for oral administration containing non-hygroscopic salts of L-carnitine and the alkanoyl L-carnitines with taurine chloride and glycine chloride
PCT/IT2001/000503 WO2002036543A1 (en) 2000-10-31 2001-09-28 Solid compositions suitable for oral administration containing non-hygroscopic salts of l-carnitine and the alkanoyl l-carnitines with taurine chloride and glycine chloride
CA2427482A CA2427482C (en) 2000-10-31 2001-09-28 Solid compositions suitable for oral administration containing non-hygroscopic salts of l-carnitine and the alkanoyl l-carnitines with taurine chloride and glycine chloride
CNB018182941A CN1219748C (zh) 2000-10-31 2001-09-28 含有l－肉碱和烷酰基l－肉碱与牛磺酸氯化物和甘氨酸氯化物形成的非吸湿性盐的适合于口服给药的固体组合物
SK501-2003A SK287133B6 (sk) 2000-10-31 2001-09-28 Soľ L-karnitínu alebo alkanoyl L-karnitínu s taurínchloridom a kompozícia s jej obsahom
AU9589301A AU9589301A (en) 2000-10-31 2001-09-28 Solid compositions suitable for oral administration containing non-hygroscopic salts of l-carnitine and the alkanoyl l-carnitines with taurine chloride and glycine chloride
RU2003116133/04A RU2270191C2 (ru) 2000-10-31 2001-09-28 Твердые композиции для перорального применения, содержащие негигроскопичные соли l-карнитина и алканоил l-карнитинов с тауринхлоридом
SI200130462T SI1330428T1 (sl) 2000-10-31 2001-09-28 Cvrsta zmes, ki je primerna za oralno administracijo in vsebuje nehigroskopicne soli L-karnitina inalkanoil L-karnitinov s taurin kloridom
PL364823A PL205801B1 (pl) 2000-10-31 2001-09-28 Kompozycje stałe odpowiednie do podawania doustnego, zawierające niehigroskopijne sole L-karnityny i alkanoilo-L-karnityny z chlorkiem tauryny
DE60115944T DE60115944T2 (de) 2000-10-31 2001-09-28 Feste zusammensetzungen für orale verabreichung die nicht-hygroskopische salze von l-karnitin und alkanoyl-l-karnitin mit taurinchlorid enthalten
DK01976633T DK1330428T3 (da) 2000-10-31 2001-09-28 Faste præparater til oral administration indeholdende ikke-hygroskopiske salte af L-carnitin og alkanoyl-L-carnitiner med taurinchlorid
AU2001295893A AU2001295893B2 (en) 2000-10-31 2001-09-28 Solid compositions suitable for oral administration containing non-hygroscopic salts of L-carnitine and the alkanoyl L-carnitines with taurine chloride and glycine chloride
EP01976633A EP1330428B1 (en) 2000-10-31 2001-09-28 Solid compositions suitable for oral administration containing non-hygroscopic salts of l-carnitine and the alkanoyl l-carnitines with taurine chloride
CZ20031041A CZ302802B6 (cs) 2000-10-31 2001-09-28 Tuhé prípravky obsahující nehygroskopické sole L-karnitinu a alkanoyl-L-karnitinu s taurinchloridem pro orální podávání
NZ525333A NZ525333A (en) 2000-10-31 2001-09-28 Solid compositions suitable for oral administration containing non-hygroscopic salts of L-carnitine and the alkanoyl L-carnitines with taurine chloride and glycine chloride
MXPA03003799A MXPA03003799A (es) 2000-10-31 2001-09-28 Composiciones solidas apropiadas para la administracion oral que contienen sales no higroscopicas de l-carnitina y l-carnitinas de alcanoilo con cloruro de taurina y cloruro de glicina.
ZA200303328A ZA200303328B (en) 2000-10-31 2003-04-30 Solid compositions suitable for oral administration containing non-hygroscopic salts of L-carnitine and the alkanoyl L-carnitines with taurine chloride and glycine chloride.
HK04104342A HK1061230A1 (en) 2000-10-31 2004-06-16 Solid compositions suitable for oral administration containing non-hygroscopic salts of l-carnitine and the alkanoyl l-carnitines with taurine chloride nad glycine chloride
CY20061100074T CY1106062T1 (el) 2000-10-31 2006-01-19 Στepεες συνθεσεις που ειναι καταλληλες για εκ του στοματος χορηγηση που πepιεχουν μη-υγροσκοπικα αλατα της l-καρνιτινης και των αλκανοϋλ l-καρνιτινων με χλωριουχο ταυρινη

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2000RM000567A IT1317924B1 (it) 2000-10-31 2000-10-31 Composizioni solide atte alla somministrazione orale comprendenti salinon igroscopici della l-carnitina e delle alcanoil l-carnitine con

Publications (3)

Publication Number Publication Date
ITRM20000567A0 true ITRM20000567A0 (it) 2000-10-31
ITRM20000567A1 ITRM20000567A1 (it) 2002-05-01
IT1317924B1 IT1317924B1 (it) 2003-07-15

Family

ID=11454973

Family Applications (1)

Application Number Title Priority Date Filing Date
IT2000RM000567A IT1317924B1 (it) 2000-10-31 2000-10-31 Composizioni solide atte alla somministrazione orale comprendenti salinon igroscopici della l-carnitina e delle alcanoil l-carnitine con

Country Status (25)

Country Link
US (1) US7858820B2 (it)
EP (1) EP1330428B1 (it)
JP (1) JP4181406B2 (it)
KR (1) KR100764155B1 (it)
CN (1) CN1219748C (it)
AT (1) ATE312810T1 (it)
AU (2) AU9589301A (it)
BR (1) BRPI0115019B1 (it)
CA (1) CA2427482C (it)
CY (1) CY1106062T1 (it)
CZ (1) CZ302802B6 (it)
DE (1) DE60115944T2 (it)
DK (1) DK1330428T3 (it)
ES (1) ES2253430T3 (it)
HK (1) HK1061230A1 (it)
HU (1) HU229989B1 (it)
IT (1) IT1317924B1 (it)
MX (1) MXPA03003799A (it)
NZ (1) NZ525333A (it)
PL (1) PL205801B1 (it)
RU (1) RU2270191C2 (it)
SI (1) SI1330428T1 (it)
SK (1) SK287133B6 (it)
WO (1) WO2002036543A1 (it)
ZA (1) ZA200303328B (it)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005031705A1 (de) * 2005-07-05 2007-01-18 Henkel Kgaa Mittel, enthaltend L-Carnitin oder L-Carnitinderivate und mindestens eine weitere Substanz ausgewählt aus Taurin und dessen Derivaten und mindestens einem Wirkstoff, erhältlich aus Pflanzen der Gattung Echinacea
KR101007927B1 (ko) 2008-12-24 2011-01-14 주식회사 셀트리온제약 시부트라민-ｌ-카르니틴 다이술폰산염, 이의 제조방법 및 이를 포함하는 약제학적 조성물
JP5451558B2 (ja) * 2010-08-27 2014-03-26 シグマ−タウ・インドゥストリエ・ファルマチェウチケ・リウニテ・ソシエタ・ペル・アチオニ 美容活性成分の送達に有用なゲル
CN104276986B (zh) * 2013-07-12 2016-07-06 辽宁科硕营养科技有限公司 左旋肉碱牛磺酸盐的制备方法
JP6473352B2 (ja) * 2015-03-10 2019-02-20 利幸 糸井 虚血性疾患治療薬
CN107325013B (zh) * 2016-04-28 2019-04-12 辽宁科硕营养科技股份有限公司 一种合成甘氨酸丙酰左旋肉碱盐酸盐的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0150688B1 (en) * 1983-12-28 1987-04-22 Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. Salts of l-carnitine and alkanoyl l-carnitines and process for preparing same
CA2030310A1 (en) * 1989-12-22 1991-06-23 Ronald E. Macleay Derivatives of n-hals-substituted amic acid hydrazides
IT1291126B1 (it) * 1997-04-01 1998-12-29 Sigma Tau Ind Farmaceuti Composizioni solide atte alla somministrazione orale comprendenti sali non igroscopici della l-carnitina e delle alcanoil l-carnitine
IT1306147B1 (it) * 1999-05-28 2001-05-30 Biosalts Srl Derivati di principi attivi ad attivita' terapeutica e/o nutrizionalee composizioni atte alla somministrazione orale contenenti tali

Also Published As

Publication number Publication date
BR0115019A (pt) 2003-12-23
DK1330428T3 (da) 2006-04-18
AU9589301A (en) 2002-05-15
US20040024061A1 (en) 2004-02-05
CZ20031041A3 (cs) 2003-08-13
MXPA03003799A (es) 2004-04-20
EP1330428B1 (en) 2005-12-14
BRPI0115019B1 (pt) 2015-10-06
CZ302802B6 (cs) 2011-11-16
CY1106062T1 (el) 2011-06-08
PL205801B1 (pl) 2010-05-31
US7858820B2 (en) 2010-12-28
NZ525333A (en) 2004-06-25
JP2004513107A (ja) 2004-04-30
KR100764155B1 (ko) 2007-10-08
ZA200303328B (en) 2004-03-09
CN1473144A (zh) 2004-02-04
RU2270191C2 (ru) 2006-02-20
KR20030059211A (ko) 2003-07-07
ITRM20000567A1 (it) 2002-05-01
SK5012003A3 (en) 2003-11-04
DE60115944D1 (de) 2006-01-19
PL364823A1 (en) 2004-12-27
HUP0302294A2 (hu) 2003-10-28
HUP0302294A3 (en) 2005-05-30
ES2253430T3 (es) 2006-06-01
CA2427482A1 (en) 2002-05-10
WO2002036543A1 (en) 2002-05-10
EP1330428A1 (en) 2003-07-30
JP4181406B2 (ja) 2008-11-12
SI1330428T1 (sl) 2006-04-30
DE60115944T2 (de) 2006-06-29
HU229989B1 (hu) 2015-04-28
IT1317924B1 (it) 2003-07-15
HK1061230A1 (en) 2004-09-10
CA2427482C (en) 2010-04-27
CN1219748C (zh) 2005-09-21
ATE312810T1 (de) 2005-12-15
AU2001295893B2 (en) 2006-11-30
SK287133B6 (sk) 2010-01-07

Similar Documents

Publication Publication Date Title
NO20030550L (no) 17<beta>-karbotioat 17<alfa>-arylkarbonyloksyandrostanderivat som anti-inflammatoriske midler
PT1110543E (pt) Composicao de libertacao prolongada para administracao oral
NO20020208D0 (no) Flytende sammensetninger for oral administrasjon
HRPK20040323B3 (en) Oral dosage form for propiverine or its pharmaceutically acceptable salts with an extended release of the active ingredient
DK1156777T3 (da) Præparat til oral administration til inhibering af dårlig ånde
ATE392464T1 (de) Zusammensetzungen enthaltend verzweigte primäre alkohole und deren derivate
NO20034778D0 (no) Farmasöytiske sammensetninger for oral og topisk anvendelse
EE200300293A (et) Makroliidühendite konjugaadid põletikuvastaste ühenditega, nende valmistamismeetodid ja kasutamine
ITRM970254A0 (it) Composizioni solide atte alla somministrazione orale comprendenti l-carnitina e alcanoil l-carnitine magnesio fumarato
ITRM20000567A0 (it) Composizioni solide atte alla somministrazione orale comprendenti sali non igroscopici della l-carnitina e delle alcanoil l-carnitine con l'
NO971832D0 (no) Orale formuleringer med forlenget frigivelse inneholdende cisaprid
ITMI20000964A0 (it) Dispositivo ortodontico per l'allineamento e lo spostamento dei denti
ITRM980445A0 (it) Composizioni solide atte alla somministrazione orale comprendenti sali non igroscopici della l-carnitina e delle alcanoil l-carnitine
DK1216032T3 (da) Orale formuleringer med kontrolleret frigivelse
ITMI20000050A0 (it) Procedimento per la preparazione della 5-carbossiftalide
EE04095B1 (et) Ketoliidide ja nende farmatseutiliselt vastuvõetavate soolade kasutamine farmatseutiliste kompositsioonide valmistamiseks
IT1291121B1 (it) Composizioni solide atte alla somministrazione orale comprendenti sali non igroscopici della l-carnitina e delle alcanoil l-carnitine
ITRM990550A0 (it) Sali non igroscopici di principi attivi ad attivita' terapeutica e/o nutrizionale e composizioni atte alla somministrazione orale contenenti
NO20003799D0 (no) Innkorporering av kolesterol-senkende midler i konfektdosisformer
DK1058536T3 (da) Sammensætninger med reduceret hudirritation
IT1313567B1 (it) Uso della n-acetil-cisteina per la preparazione di composizionifarmaceutiche topiche per il trattamento di patologie allergiche delle
ITMI20001825A1 (it) Uso dell'r(-) flurbiprofen nella preparazione di un medicamento antipiretico
IT1299071B1 (it) Composizione per l'igiene orale per l'uso nella disassuefazione al fumo
FR2818131B1 (fr) Composition cosmetique comprenant de l'heparanase
ATE427732T1 (de) Orale zusammensetzung enthaltend kreide